Latest

• Cost-effective and robust genotyping using double-mismatch allele-specific quantitative PCR
• High-throughput PCR assay design for targeted resequencing using primerXL
• Single-Nucleotide Polymorphisms and Other Mismatches Reduce Performance of Quantitative PCR Assays
• Effective Alu Repeat Based RT-Qpcr Normalization in Cancer Cell Perturbation Experiments
• Focal DNA Copy Number Changes in Neuroblastoma Target MYCN Regulated Genes
• Molecular diagnostics for congenital hearing loss including 15 deafness genes using a next generation sequencing platform
• Massively parallel sequencing for early molecular diagnosis in Leber congenital amaurosis
• Practical Tools to Implement Massive Parallel Pyrosequencing of PCR Products in Next Generation Molecular Diagnostics
• The microRNA body map: dissecting microRNA function through integrative genomics
• Dickkopf-3 is regulated by the MYCN-induced miR-17-92 cluster in neuroblastoma
• Identification of a novel recurrent 1q42.2-1qter deletion in high risk MYCN single copy 11q deleted neuroblastomas
• Analysing 454 amplicon resequencing experiments using the modular and database oriented Variant Identification Pipeline
• RNA pre-amplification enables large-scale RT-qPCR gene-expression studies on limiting sample amounts
• External oligonucleotide standards enable cross laboratory comparison and exchange of real-time quantitative PCR data
• External oligonucleotide standards enable cross laboratory comparison and exchange of real-time quantitative PCR data
• The emerging molecular pathogenesis of neuroblastoma: implications for improved risk assessment and targeted therapy
• Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas
• Aberrant methylation of candidate tumor suppressor genes in neuroblastoma
• Identification of MYCN transcriptional target genes in neuroblastoma